Edition:
United States

Cambrex Corp (CBM.N)

CBM.N on New York Stock Exchange

46.55USD
18 Jun 2018
Change (% chg)

-- (--)
Prev Close
$46.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
60,730
52-wk High
$62.25
52-wk Low
$42.55

Chart for

About

Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the... (more)

Overall

Beta: 2.28
Market Cap(Mil.): $1,537.56
Shares Outstanding(Mil.): 32.96
Dividend: --
Yield (%): --

Financials

  CBM.N Industry Sector
P/E (TTM): 14.60 29.92 34.14
EPS (TTM): 3.19 -- --
ROI: 17.16 13.64 13.17
ROE: 20.92 15.43 15.14

BRIEF-Cambrex Q1 EPS $0.32 From Continuing Operations

* Q1 EARNINGS PER SHARE $0.32 FROM CONTINUING OPERATIONS EXCLUDING ITEMS

May 03 2018

BRIEF-Cambrex Reports Q4 Adj. Earnings Per Share $1.27 From Continuing Operations

* CAMBREX REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Feb 08 2018

BRIEF-Cambrex Announces Investment At Its Charles City, Iowa Plant

* CAMBREX CORP - ANNOUNCED AN INVESTMENT TO EXPAND CHEMICAL AND ANALYTICAL DEVELOPMENT CAPABILITIES AT ITS CHARLES CITY, IOWA PLANT

Jan 30 2018

BRIEF-Cambrex & Astrazeneca Hold Ceremony To Mark Long-Term Supply Agreement At Karlskoga, Sweden Facility

* CAMBREX & ASTRAZENECA HOLD CEREMONY TO MARK LONG-TERM SUPPLY AGREEMENT AT KARLSKOGA, SWEDEN FACILITY Source text for Eikon: Further company coverage:

Jan 16 2018

Earnings vs. Estimates